Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| astrocyte | 7 studies | 35% ± 17% | |
| glutamatergic neuron | 5 studies | 37% ± 25% | |
| oligodendrocyte precursor cell | 5 studies | 32% ± 15% | |
| endothelial cell | 4 studies | 28% ± 6% | |
| epithelial cell | 3 studies | 27% ± 14% | |
| GABAergic neuron | 3 studies | 43% ± 17% | |
| interneuron | 3 studies | 47% ± 21% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 6 studies | 34% ± 19% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 2631.75 | 1445 / 1445 | 100% | 31.33 | 183 / 183 |
| stomach | 100% | 1488.87 | 359 / 359 | 100% | 18.92 | 286 / 286 |
| lung | 100% | 2025.58 | 577 / 578 | 100% | 28.36 | 1155 / 1155 |
| intestine | 100% | 2075.89 | 966 / 966 | 100% | 19.26 | 526 / 527 |
| breast | 100% | 1909.06 | 459 / 459 | 100% | 26.62 | 1114 / 1118 |
| brain | 100% | 2251.68 | 2631 / 2642 | 100% | 31.01 | 705 / 705 |
| uterus | 100% | 1831.42 | 170 / 170 | 99% | 28.98 | 456 / 459 |
| bladder | 100% | 2020.62 | 21 / 21 | 99% | 21.66 | 500 / 504 |
| prostate | 100% | 2532.27 | 245 / 245 | 99% | 18.55 | 498 / 502 |
| thymus | 100% | 1957.88 | 653 / 653 | 99% | 22.60 | 600 / 605 |
| ovary | 100% | 1895.42 | 180 / 180 | 99% | 17.84 | 426 / 430 |
| pancreas | 100% | 1264.65 | 327 / 328 | 99% | 16.23 | 176 / 178 |
| kidney | 100% | 1357.42 | 89 / 89 | 98% | 15.07 | 887 / 901 |
| skin | 100% | 3380.77 | 1809 / 1809 | 98% | 18.71 | 464 / 472 |
| adrenal gland | 100% | 1544.92 | 258 / 258 | 94% | 9.28 | 216 / 230 |
| liver | 100% | 982.73 | 226 / 226 | 88% | 9.58 | 357 / 406 |
| adipose | 100% | 1532.05 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 30.47 | 29 / 29 |
| muscle | 100% | 1889.72 | 803 / 803 | 0% | 0 | 0 / 0 |
| spleen | 100% | 3182.17 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 42.76 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 10.74 | 1 / 1 |
| blood vessel | 100% | 1957.19 | 1333 / 1335 | 0% | 0 | 0 / 0 |
| heart | 93% | 1087.82 | 805 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 93% | 12.07 | 74 / 80 |
| peripheral blood | 92% | 1892.99 | 857 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0060304 | Biological process | regulation of phosphatidylinositol dephosphorylation |
| GO_0046856 | Biological process | phosphatidylinositol dephosphorylation |
| GO_0006661 | Biological process | phosphatidylinositol biosynthetic process |
| GO_0005829 | Cellular component | cytosol |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0016020 | Cellular component | membrane |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0004438 | Molecular function | phosphatidylinositol-3-phosphate phosphatase activity |
| GO_0042803 | Molecular function | protein homodimerization activity |
| GO_0052629 | Molecular function | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity |
| Gene name | MTMR1 |
| Protein name | Myotubularin related protein 1 MTMR1 protein (Myotubularin related protein 1) Phosphatidylinositol-3,5-bisphosphate 3-phosphatase (EC 3.1.3.64) (EC 3.1.3.95) (Phosphatidylinositol-3-phosphate phosphatase) Myotubularin-related protein 1 (Phosphatidylinositol-3,5-bisphosphate 3-phosphatase) (EC 3.1.3.95) (Phosphatidylinositol-3-phosphate phosphatase) (EC 3.1.3.64) |
| Synonyms | hCG_1640369 |
| Description | FUNCTION: Lipid phosphatase that has high specificity for phosphatidylinositol 3-phosphate and has no activity with phosphatidylinositol 4-phosphate, phosphatidylinositol (4,5)-bisphosphate and phosphatidylinositol (3,4,5)-trisphosphate . Activity with phosphatidylinositol (3,5)-bisphosphate is controversial; it has been shown by PubMed:27018598, while PubMed:11733541 find no activity with this substrate. . |
| Accessions | ENST00000436701.5 F8W764 ENST00000434699.6 ENST00000438018.5 E9PPP8 F8WA39 H0YDX3 ENST00000439546.6 ENST00000445323.7 ENST00000542156.5 F8W8S8 Q13613 ENST00000493995.6 ENST00000488357.1 H7C406 H7BZJ1 E9PIH9 ENST00000490316.7 ENST00000370390.7 [Q13613-1] ENST00000485376.5 [Q13613-2] ENST00000429965.6 B7Z3D5 Q8NEC6 |